Literature DB >> 30175397

Testicular morphology in hypogonadotropic hypogonadism after the abuse of anabolic steroids.

Armin Alibegović1.   

Abstract

Hypogonadism in men results from the failure of the testes to produce physiological levels of testosterone and a normal number of spermatozoa due to a disruption of the hypothalamic-pituitary-testicular axis. An example of secondary hypogonadism as a result of anabolic steroid abuse is presented with the case report of a man who committed suicide after a history of aggressive behavior and physical abuse of his wife. The autopsy revealed shrunken testicles, with more than 30% of parenchymatous sclerosis, absent spermatogenesis, and very few Leydig cells detected only by immunohistochemistry. A low-specific immunochemical analysis revealed a very high level of total testosterone (serum 109.8 nmol/L; urine 81.2 nmol/L). A more accurate analysis confirmed an overdose of synthetic anabolic steroids. Doctors in different medical areas should be alerted to chronic abusers of synthetic anabolic steroids among the growing number of recreational athletes.

Entities:  

Keywords:  Anabolic steroids; Erectile dysfunction; Fertility; Hypogonadotropic hypogonadism; Leydig cells; Testosterone

Mesh:

Substances:

Year:  2018        PMID: 30175397     DOI: 10.1007/s12024-018-0015-6

Source DB:  PubMed          Journal:  Forensic Sci Med Pathol        ISSN: 1547-769X            Impact factor:   2.007


  8 in total

1.  Concomitant abuse of anabolic androgenic steroids and human chorionic gonadotrophin impairs spermatogenesis in power athletes.

Authors:  T Karila; O Hovatta; T Seppälä
Journal:  Int J Sports Med       Date:  2004-05       Impact factor: 3.118

2.  Identification of late-onset hypogonadism in middle-aged and elderly men.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Jennifer M Beynon; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe F Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Michael E J Lean; Neil Pendleton; Margus Punab; Steven Boonen; Dirk Vanderschueren; Fernand Labrie; Ilpo T Huhtaniemi
Journal:  N Engl J Med       Date:  2010-06-16       Impact factor: 91.245

3.  Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.

Authors:  S M Harman; E J Metter; J D Tobin; J Pearson; M R Blackman
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

Review 4.  Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.

Authors:  Shalender Bhasin; Glenn R Cunningham; Frances J Hayes; Alvin M Matsumoto; Peter J Snyder; Ronald S Swerdloff; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2010-06       Impact factor: 5.958

5.  Reversible testosterone-induced azoospermia in a 45-year-old man attending an infertility outpatient clinic.

Authors:  Z Jan; M Pfeifer; B Zorn
Journal:  Andrologia       Date:  2011-07-18       Impact factor: 2.775

6.  Effects of anabolic steroid (19-nortestosterone) on the secretion of testicular hormones in the stallion.

Authors:  S Nagata; M Kurosawa; K Mima; Y Nambo; Y Fujii; G Watanabe; K Taya
Journal:  J Reprod Fertil       Date:  1999-03

Review 7.  Anabolic steroids and male infertility: a comprehensive review.

Authors:  Guilherme Leme de Souza; Jorge Hallak
Journal:  BJU Int       Date:  2011-06-17       Impact factor: 5.588

Review 8.  Diagnosis and treatment of hypogonadism in men.

Authors:  Shalender Bhasin; Shehzad Basaria
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-04       Impact factor: 4.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.